BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”) in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The offering is expected to c ...

BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”). The Notes will be guaranteed (the “Gu ...

Core Insights - Surgery Partners, Inc. reported a 6.6% increase in revenues for Q3 2025, reaching $821.5 million compared to $770.4 million in Q3 2024, with same-facility revenues up 6.3% [3][4] - The company adjusted its full-year 2025 revenue guidance to a range of $3.275 billion to $3.30 billion and Adjusted EBITDA guidance to $535 million to $540 million, reflecting a cautious outlook due to softer volume and payor mix trends [2][4] - Adjusted EBITDA for Q3 2025 was $136.4 million, a 6.1% increase from $128.6 million in Q3 2024, indicating operational resilience despite challenges [3][7] Financial Performance - Year-to-date revenues for 2025 increased by 7.7% to $2,423.7 million compared to $2,249.9 million in the same period of 2024, with same-facility revenues up 5.4% [4][6] - The company reported a net loss attributable to Surgery Partners, Inc. of $22.7 million for Q3 2025, an improvement from a loss of $31.7 million in Q3 2024 [7][19] - Operating cash flows for Q3 2025 were $83.6 million, up from $65.2 million in Q3 2024, driven by operational growth and reduced transaction-related costs [5][6] Operational Metrics - The number of surgical cases increased by 2.1% in Q3 2025, with same-facility cases rising by 3.4% [7][25] - Revenue per case for Q3 2025 was $4,946, reflecting a 2.8% increase from the previous year [25][27] - As of September 30, 2025, Surgery Partners operated 165 surgical facilities, maintaining the same number as the previous year [25][21] Liquidity and Debt - As of September 30, 2025, the company had cash and cash equivalents of $203.4 million and $405.9 million in borrowing capacity under its revolving credit facility [5][21] - The ratio of total net debt to EBITDA was approximately 4.2x at the end of Q3 2025, indicating a stable leverage position [8][21]

Core Viewpoint - Surgery Partners, Inc. is set to release its third quarter 2025 results on November 10, 2025, followed by a conference call for investors [1]. Company Overview - Surgery Partners is a leading healthcare services company headquartered in Brentwood, Tennessee, focusing on high-quality, cost-effective surgical and ancillary care solutions [3]. - The company operates over 200 locations across 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities [3]. - Founded in 2004, Surgery Partners is recognized as one of the largest and fastest-growing surgical services businesses in the United States [3]. Investor Relations - Interested parties can access the conference call via a live webcast on the company's Investor Relations website, with a replay available for a limited time [1]. - Contact information for investor relations includes a dedicated phone line and email for inquiries [4].

Company Overview - Surgery Partners, Inc. is a leading healthcare services company focused on providing high-quality, cost-effective surgical and ancillary care solutions [3] - The company operates more than 200 locations across 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities [3] - Founded in 2004, Surgery Partners is recognized as one of the largest and fastest-growing surgical services businesses in the United States [3] Upcoming Financial Results - Surgery Partners will release its second quarter 2025 results before the market opens on August 5, 2025 [1] - A conference call will follow at 8:30 a.m. Eastern Time on the same day [1] - Interested parties can access the call via a webcast on the company's Investor Relations website, with a replay available for a limited time [1][2] Investor Relations - The company provides material information through its website, ensuring easy access for investors [2] - Contact information for investor relations includes a dedicated phone line and email address for inquiries [4] - Live access to the conference call is available through specific dial-in numbers for domestic and international participants [4]

Core Viewpoint - Surgery Partners, Inc. has reaffirmed its confidence in its long-term growth prospects and reiterated its full-year 2025 financial guidance, indicating a strong outlook for the company as an independent entity [1][2]. Company Overview - Surgery Partners is a leading healthcare services company focused on outpatient surgical care, operating over 200 locations across 30 states [6][8]. - The company utilizes a joint venture model and has a strong track record in mergers and acquisitions, positioning it well in the high-growth outpatient surgical care market [3]. Financial Guidance - The company expects 2025 revenues to be in the range of $3.30 billion to $3.45 billion and Adjusted EBITDA to be between $555 million and $565 million [5]. Strategic Initiatives - Surgery Partners plans to host an Investor Day in the second half of 2025 to discuss its future growth plans, industry trends, and strategies for maximizing portfolio performance and operational efficiencies [4]. Board and Management Confidence - The Independent Committee of the Board, after reviewing a non-binding acquisition proposal from Bain Capital, concluded that remaining independent would better serve the long-term interests of the company and its shareholders [2][3]. - The management team, led by CEO Eric Evans, expressed confidence in achieving the financial guidance for 2025, supported by favorable surgical trends and a positive regulatory outlook [3].

Core Insights - Surgery Partners, Inc. reported a strong start to 2025 with revenues increasing by 8.2% year-over-year to $776.0 million, driven by a 5.2% increase in same-facility revenues and a 6.5% increase in same-facility cases [3][6][21] - The company reaffirmed its full-year 2025 revenue guidance in the range of $3.30 billion to $3.45 billion and Adjusted EBITDA guidance between $555 million and $565 million, indicating confidence in continued growth and margin expansion [2][6] - Despite the positive revenue growth, the company reported a net loss attributable to Surgery Partners, Inc. of $37.7 million for the first quarter, compared to a net loss of $12.4 million in the same period last year [3][21] Financial Performance - Adjusted EBITDA for the first quarter of 2025 was $103.9 million, reflecting a 6.6% increase from $97.5 million in the first quarter of 2024 [3][21] - The company's operating income decreased to $61.9 million from $76.0 million year-over-year, primarily due to increased operating expenses [21] - The ratio of total net debt to EBITDA was approximately 4.1x at the end of the first quarter of 2025, indicating the company's leverage position [5] Liquidity and Cash Flow - As of March 31, 2025, Surgery Partners had cash and cash equivalents of $229.3 million and $388.9 million available under its revolving credit facility [4][20] - Cash flows from operating activities decreased to $6.0 million in the first quarter of 2025 from $40.7 million in the same period of 2024, attributed to timing of routine transactions involving working capital [4][20] Operational Highlights - The number of surgical facilities decreased slightly to 164 as of March 31, 2025, from 165 a year earlier, while the number of consolidated surgical facilities also declined to 118 from 124 [20][21] - Revenue per case increased to $4,841 in the first quarter of 2025, up from $4,677 in the same period of 2024, despite a 1.2% decrease in revenue per case year-over-year [21][23]